These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 2365000

  • 1. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M.
    Eur J Pharmacol; 1990 May 03; 180(1):161-8. PubMed ID: 2365000
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH, Scholes HE, Virdi S, Broadley KJ.
    J Pharm Pharmacol; 2001 Apr 03; 53(4):487-96. PubMed ID: 11341365
    [Abstract] [Full Text] [Related]

  • 3. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
    Poli E, Monica B, Zappia L, Pozzoli C, Bertaccini G.
    Gen Pharmacol; 1992 Jul 03; 23(4):659-64. PubMed ID: 1397972
    [Abstract] [Full Text] [Related]

  • 4. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M.
    Pharmacology; 1988 Jul 03; 37 Suppl 1():40-7. PubMed ID: 2467317
    [Abstract] [Full Text] [Related]

  • 5. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
    Eltze M.
    Eur J Pharmacol; 1988 Jul 07; 151(2):205-21. PubMed ID: 2844551
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE, Sawyer BD, Bemis KG, Bymaster FP, Health I, Mitch CH, Ward JS.
    Eur J Pharmacol; 1993 Feb 23; 232(1):47-57. PubMed ID: 8458395
    [Abstract] [Full Text] [Related]

  • 7. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M, Gmelin G, Wess J, Strohmann C, Tacke R, Mutschler E, Lambrecht G.
    Eur J Pharmacol; 1988 Dec 13; 158(3):233-42. PubMed ID: 2472963
    [Abstract] [Full Text] [Related]

  • 8. The affinity, selectivity and biological activity of telenzepine enantiomers.
    Schudt C, Boer R, Eltze M, Riedel R, Grundler G, Birdsall NJ.
    Eur J Pharmacol; 1989 Jun 08; 165(1):87-96. PubMed ID: 2475354
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
    Eltze M, Gönne S, Riedel R, Schlotke B, Schudt C, Simon WA.
    Eur J Pharmacol; 1985 Jun 07; 112(2):211-24. PubMed ID: 4029260
    [Abstract] [Full Text] [Related]

  • 10. Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia.
    Galvan M, Boer R, Schudt C.
    Eur J Pharmacol; 1989 Aug 11; 167(1):1-10. PubMed ID: 2776837
    [Abstract] [Full Text] [Related]

  • 11. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L, Prosser JC, Sturm BL, Lowe VC, Enna SJ.
    Eur J Pharmacol; 1991 Aug 29; 201(2-3):135-42. PubMed ID: 1724648
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
    Adachi S, Koike K, Takayanagi I.
    Pharmacology; 1996 Oct 29; 53(4):250-8. PubMed ID: 8958564
    [Abstract] [Full Text] [Related]

  • 13. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M.
    Eur J Pharmacol; 1994 Sep 22; 263(1-2):31-7. PubMed ID: 7529712
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U, Fuder H, Moser U, Bümert HG, Mutschler E, Lambrecht G.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan 22; 349(1):1-10. PubMed ID: 8139696
    [Abstract] [Full Text] [Related]

  • 15. Conditional involvement of muscarinic M1 receptors in vagally mediated contraction of guinea-pig bronchi.
    ten Berge RE, Roffel AF, Zaagsma J.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 22; 352(2):173-8. PubMed ID: 7477440
    [Abstract] [Full Text] [Related]

  • 16. Selective antagonism by pirenzepine and N-methyl-scopolamine on muscarinic receptor subtypes of the rat vas deferens.
    Miranda HF, Silva WI, Wolstenholme WW, Cuevas N.
    Gen Pharmacol; 1988 Aug 22; 19(3):417-20. PubMed ID: 3417103
    [Abstract] [Full Text] [Related]

  • 17. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
    Dörje F, Rettenmayr NM, Mutschler E, Lambrecht G.
    Eur J Pharmacol; 1991 Oct 22; 203(3):417-20. PubMed ID: 1723047
    [Abstract] [Full Text] [Related]

  • 18. The binding of [3H]telenzepine to muscarinic acetylcholine receptors in calf forebrain.
    Schudt C, Auriga C, Kinder B, Birdsall NJ.
    Eur J Pharmacol; 1988 Jan 05; 145(1):87-90. PubMed ID: 3350039
    [Abstract] [Full Text] [Related]

  • 19. Cyproheptadine displays high affinity for muscarinic receptors but does not discriminate between receptor subtypes.
    Eltze M, Lambrecht G, Mutschler E.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):219-22. PubMed ID: 2625138
    [Abstract] [Full Text] [Related]

  • 20. Stereoselectivity at muscarinic receptor subtypes: observations with the enantiomers of phenglutarimide.
    Lambrecht G, Feifel R, Mutschler E.
    Chirality; 1989 Dec 07; 1(2):170-3. PubMed ID: 2642045
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.